[artículo] 
inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2025 - Vol. 64 - No. 2 (Febrero) . - pp. 143-157

Título :	Systematic review and network meta-analysis: efficacy and safety of antipsychotics vs antiepileptics or lithium for acute mania in children and adolescents
Tipo de documento:	texto impreso
Autores:	Giovanni Vita, Autor ; Viktor B. Nöhles, Autor ; Giovanni Ostuzzi, Autor
Fecha de publicación:	2025
Artículo en la página:	pp. 143-157
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Estabilizadores del estado de ánimo, Antipsicóticos, Trastorno bipolar pediátrico, Psiquiatría de precisión.
Resumen:	To compare second-generation antipsychotics (SGAs) and mood stabilizers (MSs) in youth with a bipolar disorder type I (BD-I) manic/mixed episode. A systematic PubMed/Embase/PsycInfo literature search until December 31, 2023, for randomized trials of SGAs or MSs in patients ≤18 years of age with BD-I manic/mixed episode was conducted. The study included a network meta-analysis comparing treatments regarding mania symptoms and mania response (co-primary outcomes), and secondary efficacy and tolerability outcomes.
Link:	./index.php?lvl=notice_display&id=31546

[artículo] Systematic review and network meta-analysis: efficacy and safety of antipsychotics vs antiepileptics or lithium for acute mania in children and adolescents [texto impreso] / Giovanni Vita, Autor ; Viktor B. Nöhles, Autor ; Giovanni Ostuzzi, Autor . - 2025 . - pp. 143-157.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2025 - Vol. 64 - No. 2 (Febrero) . - pp. 143-157

Palabras clave:	Estabilizadores del estado de ánimo, Antipsicóticos, Trastorno bipolar pediátrico, Psiquiatría de precisión.
Resumen:	To compare second-generation antipsychotics (SGAs) and mood stabilizers (MSs) in youth with a bipolar disorder type I (BD-I) manic/mixed episode. A systematic PubMed/Embase/PsycInfo literature search until December 31, 2023, for randomized trials of SGAs or MSs in patients ≤18 years of age with BD-I manic/mixed episode was conducted. The study included a network meta-analysis comparing treatments regarding mania symptoms and mania response (co-primary outcomes), and secondary efficacy and tolerability outcomes.
Link:	./index.php?lvl=notice_display&id=31546